News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Biomet Inc. 1Q Sales Disappoint, Rising 2 Percent
October 13, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Forbes -- WARSAW, Ind. --Medical device maker Biomet Inc. said Wednesday its sales rose 2 percent in the first quarter, slower than the privately held company had expected.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Startups
Novartis-, Sanofi-Backed Granite Brings $100M to Compete in Crowded I&I Space
April 24, 2025
·
2 min read
·
Tristan Manalac
Startups
Etiome Steps Out of Stealth With $50M to Address Disease At The ‘Silent Stage’
April 24, 2025
·
2 min read
·
Dan Samorodnitsky
Vaccines
Sales of Merck’s 4-Way Measles Vaccine Take Hit as US Dips Into Stockpile
April 24, 2025
·
2 min read
·
Annalee Armstrong
Tariffs
Roche in ‘Very, Very Good Position’ To Weather Trump Tariffs but M&A May Suffer
April 24, 2025
·
2 min read
·
Tristan Manalac
